DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
NNOX logo

Nano-X Imaging Ltd. Stock Price

NasdaqGM:NNOX Community·US$50.7m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 84 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

NNOX Share Price Performance

US$0.72
-3.19 (-81.49%)
​
US$3.00
Fair Value
US$0.72
-3.19 (-81.49%)
75.9% undervalued intrinsic discount
US$3.00
Fair Value
Price US$0.72
AnalystLowTarget US$3.00
AnalystConsensusTarget US$5.80
AnalystHighTarget US$7.40
Wed, 29 Jul 26
Fair ValueUS$3.00
Share Pricen/a

NNOX Community Narratives

AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$3 75.9% undervalued intrinsic discount

Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$5.8 87.5% undervalued intrinsic discount

Digital Diagnostics And AI Will Open Global Markets

1users have liked this narrative
0users have commented on this narrative
56users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$7.4 90.2% undervalued intrinsic discount

Global Aging And Digitalization Will Accelerate Imaging Adoption

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
NNOX logo
Nano-X Imaging
75.9% undervalued intrinsic discount

Rising Regulatory Hurdles Will Test Digital Imaging But Allow Revival

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 29 Jul
Read Narrative
NNOX logo
Nano-X Imaging
90.2% undervalued intrinsic discount

Global Aging And Digitalization Will Accelerate Imaging Adoption

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 15 Jul
Read Narrative
NNOX logo
Nano-X Imaging
87.5% undervalued intrinsic discount

Digital Diagnostics And AI Will Open Global Markets

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 1 Jul
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
NNOX logo

NNOX: New Peru Agreement Will Support Future Stock Upside Potential

Fair Value: US$3 75.9% undervalued intrinsic discount
5 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
NNOX logo

NNOX: Restructuring And Outsourced Production Will Drive Future Rebound Potential

Fair Value: US$7.4 90.2% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
NNOX logo

NNOX: Legal Overhang May Set Stage For Future Upside Repricing

Fair Value: US$5.8 87.5% undervalued intrinsic discount
56 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Excellent balance sheet with low risk.

3 Risks
1 Reward
View Full Analysis

Nano-X Imaging Ltd. Key Details

US$15.6m

Revenue

US$27.7m

Cost of Revenue

-US$12.1m

Gross Profit

US$104.7m

Other Expenses

-US$116.8m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.67
-77.18%
-747.19%
4.0%
View Full Analysis

About NNOX

Founded
2011
Employees
197
CEO
Erez Meltzer
WebsiteView website
www.nanox.vision

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source; and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists; Nanox.CONNECT to receive local regulatory approvals and explore and evaluate the business model and the potential service; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data of existing computed tomography scans; and Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers and mobile imaging service providers, urgent care facilities, and multi-specialty physician groups. In addition, the company provides Real+ Osteoporosis Care Management Platform, a osteoporosis care management software platform; AI-Based Aortic Valve Calcification Measurement, an artificial intelligence–based solution; AI-Based Body Composition Measurement, an artificial intelligence–based body composition analysis capability; and Nanox Health IT, a healthcare information technology services provider that serves hospitals and other healthcare organizations. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Petah Tikva, Israel.

Recent NNOX News & Updates

Recent updates

No updates

Nano-X Imaging Ltd. Competitors

STEX logo

Streamex

Symbol: NasdaqCM:STEX
Market cap: US$122.6m
APYX logo

Apyx Medical

Symbol: NasdaqGS:APYX
Market cap: US$122.2m
BRRN

Byrn

Symbol: OTCPK:BRRN
Market cap: US$115.8m
VANI logo

Vivani Medical

Symbol: NasdaqCM:VANI
Market cap: US$114.6m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide